Publikation

Photodynamic therapy of locoregional breast cancer recurrences using a chlorintype photosensitizer

Wissenschaftlicher Artikel/Review - 12.06.2001

Bereiche
DOI
Link
Kontakt

Zitation
Hornung R, Wyss P, Schwarz V, Dobler-Girdziunaite D, Walt H, Degen A, Fehr M. Photodynamic therapy of locoregional breast cancer recurrences using a chlorintype photosensitizer. International Journal of Cancer 2001; 93:720-724.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
International Journal of Cancer 2001; 93
Veröffentlichungsdatum
12.06.2001
Seiten
720-724
Kurzbeschreibung/Zielsetzung

Chest wall recurrences are a frequent problem in patients treated by mastectomy for breast cancer. Surgery and ionizing radiation are established treatment modalities in these cases. Photodynamic therapy (PDT) provides an alternative treatment modality using a photosensitizer and laser light to induce selective tumor necrosis. PDT was performed as compassionate use in 7 patients aged 57.6 years (±12.6 SD). A total of 89 metastatic skin nodes were treated in 11 PDT sessions. As photosensitizer meta-tetra(hydroxyphenyl)chlorin (m-THPC) was applied intravenously. Patients (n = 3) photosensitized with a drug dose of 0.10 mg/kg bodyweight were irradiated 48 hr after drug application at a lightdose of 5 J/cm2. Patients (n = 4) were illuminated by an optical dose of 10 J/cm2 96 hr after photosensitization with 0.15 mg/kg. Laser light at a wavelength of 652 nm was generated by a diode laser and applied by a front lens light diffuser using a fluence rate of 20–25 mW/cm2. PDT using m-THPC resulted in complete response in all patients. Response to treatment did not differ when using the 2 different drugdose protocols. Healing time depended mainly on the size of the illumination field but not on the lightdose. Pain score usually raised 1 day after PDT and lasted at higher levels for about 10 days. Healing time usually ranged between 8–10 weeks. Photodynamic technique offers a minimal-invasive, outpatient treatment modality for recurrent breast cancer on the chest wall with few side effects, high patient's satisfaction and with possible repetitive application.